Docmorris
DocMorris, officially known as DocMorris GmbH, is a leading online pharmacy headquartered in Heerlen, Netherlands, with significant operations across Germany and other European regions. Founded in 2000, DocMorris has established itself as a pioneer in the digital healthcare sector, offering a wide range of pharmaceutical products and health services. The company is renowned for its unique approach to online pharmacy, providing customers with prescription medications, over-the-counter drugs, and health-related products through a user-friendly platform. DocMorris stands out for its commitment to customer service and innovative delivery options, ensuring convenience and accessibility. As a prominent player in the online pharmacy industry, DocMorris has achieved notable milestones, including partnerships with various healthcare providers and a strong market presence, making it a trusted choice for consumers seeking reliable pharmaceutical solutions.
DitchCarbon Score
How does Docmorris's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Docmorris's score of 28 is higher than 90% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Docmorris's reported carbon emissions
In 2023, Docmorris reported total carbon emissions of approximately 7.7 million tonnes CO2e. This figure includes 260,000 tonnes CO2e from Scope 1 emissions, which encompass direct emissions from owned or controlled sources. Scope 2 emissions, primarily from purchased electricity and heat, accounted for about 2.7 million tonnes CO2e. The largest portion of their emissions, approximately 4.7 million tonnes CO2e, fell under Scope 3, which includes indirect emissions from the value chain, such as downstream transportation and distribution. Comparatively, in 2022, Docmorris's total emissions were about 8.8 million tonnes CO2e, indicating a reduction of approximately 1.1 million tonnes CO2e in 2023. This trend of decreasing emissions is a positive step towards their climate commitments, although specific reduction targets or initiatives have not been disclosed. Overall, while Docmorris has made progress in reducing its carbon footprint, further details on formal reduction targets or climate pledges are currently unavailable. The company continues to navigate its environmental impact within the pharmaceutical industry, focusing on improving sustainability practices.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 81,000 | 000,000 | 000,000 |
| Scope 2 | 3,031,000 | 0,000,000 | 0,000,000 |
| Scope 3 | 4,971,000 | 0,000,000 | 0,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Docmorris is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
